The Connective Tissue Disease Treatment Market is witnessing strong growth, driven by the increasing prevalence of autoimmune disorders, advancements in biologic therapies, and growing awareness of personalized treatment approaches. Valued at USD 24,169.10 million in 2024, the market is projected to expand at a CAGR of 5.89% through 2032. With chro